基于蛋白质多糖的纳米凝/水凝复合物,可控制药物的连续递送,可增强伤口愈合
Yi Mao1, Bingtian Zhao1, Linghui Xu1
1Key Laboratory of Synthetic and Biological Colloids, Ministry of Education, School of Chemical and Material Engineering, Jiangnan University, Wuxi 214122, China.
Carbohydrate polymers
|March 6, 2025
概括
一种新型的蛋白质多糖化水凝 (SG@CRG) 通过提供可控的药物输送来增强伤口愈合. 这种生物基复合物显示出显著的抗菌活性,并在体内促进皮肤更快的再生.
科学领域:
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
- 药物输送系统 药物输送系统
背景情况:
- 在伤口部位达到向药物度对于有效的愈合至关重要.
- 现有的药物输送系统在全厚皮肤伤口的控制释放和生物相容性方面面临挑战.
研究的目的:
- 开发一种新型的蛋白质-多糖化合物水凝 (SG@CRG),用于控制的,连续的药物输送.
- 评估SG@CRG在增强全厚皮肤伤口愈合方面的有效性.
主要方法:
- 将含有药物的螺旋藻蛋白分离物纳米凝 (SG) 纳入碳甲基酸水凝 (CRG) 网络.
- 在体外评估药物释放动力学,抗菌活性,生物相容性,抗炎和抗氧化特性.
- 在体内评估使用全厚小鼠皮肤伤口模型.
主要成果:
- SG@CRG表现出快速凝结,优良的机械性能和可调节的药物释放率.
- 证明了强大的抗菌活性,对抗阳性和阴性细菌 (例如,金黄色细菌,大肠杆菌).
- 在体内显著加快伤口愈合,改善了颗粒组织形成,原沉积和血管生成.
结论:
- 开发的SG@CRG水凝为先进的伤口愈合应用提供了一个有前途的平台.
- 这种蛋白质多糖化合物为有效的药物输送和组织再生提供了新的策略.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...


